PPARGC1A and chronic kidney disease: Several studies have revealed that PGC-1α expression is reduced in skeletal muscle atrophy induced by diseases, including cancer, diabetes and CKD (Correia et al., 2015; Su et al., 2017; Kato et al., 2021).